- Archived Press Releases
Lilly and Akouos Announce Expiration of Akouos Tender Offer (Nov 30, 2022)
View PDF
- Archived Press Releases
Akouos Reports Third Quarter 2022 Financial Results and Provides Business Highlights (Nov 14, 2022)
View PDF
- Archived Press Releases
Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss (Oct 18, 2022)
View PDF
- Archived Press Releases
Akouos Receives FDA Clearance of its IND Application for AK-OTOF, a Gene Therapy Intended for the Treatment of OTOF-mediated Hearing Loss (Sep 13, 2022)
View PDF
- Archived Press Releases
Akouos Reports Second Quarter 2022 Financial Results and Provides Business Highlights (Aug 15, 2022)
View PDF
- Archived Press Releases
Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear at the American Society of Gene and Cell Therapy 25th Annual Meeting (May 19, 2022)
View PDF
- Archived Press Releases
Akouos Reports First Quarter 2022 Financial Results and Provides Business Highlights (May 12, 2022)
View PDF
- Archived Press Releases
Akouos to Present at Bank of America 2022 Healthcare Conference (May 04, 2022)
View PDF
- Archived Press Releases
Akouos to Present at the American Society of Gene and Cell Therapy 25th Annual Meeting (May 03, 2022)
View PDF
- Archived Press Releases
Akouos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights (Mar 29, 2022)
View PDF
- Archived Press Releases
Akouos to Participate in Upcoming March Virtual Investor Conferences (Mar 24, 2022)
View PDF
- Archived Press Releases
Akouos Appoints Aaron Tward, M.D., Ph.D., as Chief Scientific Officer (Mar 10, 2022)
View PDF
- Archived Press Releases
Akouos to Present at Cowen 42nd Annual Heath Care Conference (Mar 01, 2022)
View PDF
- Archived Press Releases
Akouos Presents Nonclinical Data Demonstrating Potential Applicability of Precision Genetic Medicine Platform for a Broad Range of Inner Ear Conditions at the Association for Research in Otolaryngology 45th Annual Mid-Winter Meeting (Feb 07, 2022)
View PDF
- Archived Press Releases
Akouos to Participate in Upcoming February Virtual Investor Conferences (Jan 31, 2022)
View PDF
- Archived Press Releases
Akouos to Present at the Association for Research in Otolaryngology 45th Annual Mid-Winter Meeting (Jan 07, 2022)
View PDF
- Archived Press Releases
Akouos to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference (Nov 22, 2021)
View PDF
- Archived Press Releases
Akouos Reports Third Quarter 2021 Financial Results and Provides Business Highlights (Nov 12, 2021)
View PDF
- Archived Press Releases
Akouos Appoints Stacy Price as Chief Technical Officer (Nov 01, 2021)
View PDF
- Archived Press Releases
Akouos to Present at Jefferies Gene Therapy/Editing Summit (Oct 20, 2021)
View PDF
- Archived Press Releases
Akouos to Present at Upcoming September Virtual Investor Conferences (Sep 07, 2021)
View PDF
- Archived Press Releases
Akouos Reports Second Quarter 2021 Financial Results and Provides Business Highlights (Aug 12, 2021)
View PDF
- Archived Press Releases
Akouos Announces European Commission Designation of AK-OTOF for the Treatment of Otoferlin Gene-Mediated Hearing Loss as an Orphan Drug (Aug 11, 2021)
View PDF
- Archived Press Releases
Akouos to Present at Upcoming August Virtual Investor Conferences (Aug 04, 2021)
View PDF
- Archived Press Releases
Akouos Reports First Quarter 2021 Financial Results and Provides Business Updates (May 13, 2021)
View PDF
- Archived Press Releases
Akouos Presents Nonclinical Data Supporting Future Clinical Development of AK-OTOF and AK-antiVEGF at the American Society of Gene and Cell Therapy 24th Annual Meeting (May 11, 2021)
View PDF
- Archived Press Releases
Akouos Appoints Dr. Kathy Reape as Chief Development Officer (May 07, 2021)
View PDF
- Archived Press Releases
Akouos to Present at Bank of America 2021 Virtual Healthcare Conference (May 07, 2021)
View PDF
- Archived Press Releases
Akouos to Present Nonclinical Data from AK-OTOF and AK-antiVEGF Programs at the American Society of Gene and Cell Therapy 24th Annual Meeting (Apr 27, 2021)
View PDF
- Archived Press Releases
Akouos Receives Orphan Drug and Rare Pediatric Disease Designations for AK-OTOF for the Treatment of Otoferlin Gene-Mediated Hearing Loss (Apr 13, 2021)
View PDF
- Archived Press Releases
Akouos to Present at 20th Annual Needham Virtual Healthcare Conference (Apr 08, 2021)
View PDF
- Archived Press Releases
Akouos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights (Mar 29, 2021)
View PDF
- Archived Press Releases
Akouos and Blueprint Genetics Announce the Resonate Program to Improve Access to Genetic Testing for Individuals with Auditory Neuropathy (Jan 11, 2021)
View PDF
- Archived Press Releases
Akouos to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference (Nov 23, 2020)
View PDF
- Archived Press Releases
Akouos Reports Third Quarter 2020 Financial Results and Provides Business Highlights (Nov 12, 2020)
View PDF
- Archived Press Releases
Akouos Announces Key Leadership Appointments (Oct 01, 2020)
View PDF
- Archived Press Releases
Akouos to Present at Upcoming October Virtual Investor Conferences (Sep 24, 2020)
View PDF
- Archived Press Releases
Akouos to Present at Cantor Global Virtual Healthcare Conference (Sep 08, 2020)
View PDF
- Archived Press Releases
Akouos Reports Second Quarter 2020 Financial Results and Provides Business Highlights (Aug 13, 2020)
View PDF
- Archived Press Releases
Akouos Announces Expansion of Executive Team and Board of Directors (Aug 05, 2020)
View PDF
- Archived Press Releases
Akouos to Present at BTIG Virtual Biotechnology Conference (Aug 03, 2020)
View PDF
- Archived Press Releases
Akouos Announces Closing of Initial Public Offering (Jun 30, 2020)
View PDF
- Archived Press Releases
Akouos Announces Pricing of Initial Public Offering (Jun 25, 2020)
View PDF
- Archived Press Releases
Akouos To Present Data from Inner Ear Gene Therapy Platform at 23rd ASGCT Annual Meeting (May 11, 2020)
View PDF
- Archived Press Releases
Akouos Closes $105 Million Series B Financing (Mar 03, 2020)
View PDF
- Archived Press Releases
Akouos Announces New Data at The Association for Research in Otolaryngology Midwinter Meeting (Jan 24, 2020)
View PDF
- Archived Press Releases
Akouos Announces Senior Leadership Team Appointments (Jan 09, 2020)
View PDF
- Archived Press Releases
Akouos Appoints Rabia Gurses Ozden, M.D., As Chief Development Officer (Oct 24, 2019)
View PDF
- Archived Press Releases
Akouos Launches The Sing Registry to Inform Future Therapeutic Development For Genetic Sensorineural Hearing Loss (Sep 13, 2019)
View PDF
- Archived Press Releases
Akouos Discloses Lead Program, AK-OTOF, A Potential Gene Therapy For Sensorineural Hearing Loss (Sep 12, 2019)
View PDF
- Archived Press Releases
Akouos Announces Executive Leadership Team Appointments (Sep 03, 2019)
View PDF
- Archived Press Releases
Akouos to Participate in Upcoming Investor Conferences (Aug 09, 2019)
View PDF
- Archived Press Releases
Akouos Announces New Data at the American Society of Gene & Cell Therapy 2019 Annual Meeting (Apr 15, 2019)
View PDF
- Archived Press Releases
Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore And Preserve Hearing (Aug 07, 2018)
View PDF